Re: Robert J. Motzer, Paul Russo, Naomi Haas, et al. Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial. Eur Urol 2021;79:334–8: PROTECTing Patients with Locally Advanced Kidney Cancer
Publication date: Available online 4 May 2021Source: European UrologyAuthor(s): Nirmish Singla, Phillip Pierorazio, Mohamad Allaf, Yasser Ged
Source: European Urology - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Urology & Nephrology